ask="N/A"
ask_size="N/A"
average_daily_volume="780324"
bid="N/A"
bid_size="N/A"
book_value="-0.4130"
change="-0.0095"
change_from_200_day_moving_average="-0.1295"
change_from_50_day_moving_average="-0.0686"
change_from_52_week_high="-0.9301"
change_From_52_week_low="0.3199"
change_in_percent="-1.6118%"
close="0.5799"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0830"
ebitda="-1.60M"
eps_estimate_current_year="-0.0800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0300"
ex_dividend_date="N/A"
float_shares="133560000"
high="0.5901"
high_52_weeks="1.5100"
last_trade_date="1/24/2017"
last_trade_price="0.5799"
last_trade_size="451"
last_trade_time="4:02pm"
low="0.5716"
low_52_weeks="0.2600"
market_capitalization="90.17M"
moving_average_200_day="0.7094"
moving_average_50_day="0.6485"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.2500"
open="0.5810"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-18.2567%"
percent_change_from_50_day_moving_average="-10.5762%"
percent_change_from_52_week_high="-61.5960%"
percent_change_from_52_week_low="+123.0385%"
previous_close="0.5894"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="4.0007"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="15.9100"
stock_exchange="ASE"
symbol="NAVB"
volume="510308"
weeks_range_52="0.2600 - 1.5100"
